Published in Vaccine Weekly, July 26th, 2006
"DNA vaccine represents an attractive approach to therapy of chronic HBV infection because of its ability to generate antigen-specific immunity; nevertheless, there is still a need to increase the potency of DNA vaccine," wrote X.M. Li and colleagues, University of Science & Technology of China.
They continued, M....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly